Medical Pearl: Using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis
Authors:
- Ravi S. KrishnanRKRavi S. Krishnan
- Sylvia HsuSHSylvia Hsu
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 53 (5) , 867-868
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Characterization of a Subgroup of Patients With Dermatitis Herpetiformis With Nonclassical Histologic Features.The American Journal of Dermatopathology, 2002
- Dermatitis Herpetiformis: Should Direct Immunofluorescence Be the Only Diagnostic Criterion?Pediatric Dermatology, 2002
- Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis HerpetiformisJournal of Experimental Medicine, 2002
- Tissue transglutaminase antibody assessment in dermatitis herpetiformisBritish Journal of Dermatology, 2001
- A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findingsJournal of the American Academy of Dermatology, 2000
- Antibodies to Tissue Transglutaminase as Serologic Markers in Patients with Dermatitis HerpetiformisJournal of Investigative Dermatology, 1999
- Identification of tissue transglutaminase as the autoantigen of celiac diseaseNature Medicine, 1997
- IgA antiendomysial antibodies in dermatitis herpetiformisJournal of the American Academy of Dermatology, 1989
- Thyroid Abnormalities in Dermatitis HerpetiformisAnnals of Internal Medicine, 1985
- Dermatitis herpetiformis: diagnosis, diet and demography.Gut, 1984